Crystal Structure of the Kinase Domain of MerTK in Complex with AZD7762 Provides Clues for Structure-Based Drug Development
Open Access
- 23 October 2020
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (21) , 7878
Abstract
Aberrant tyrosine-protein kinase Mer (MerTK) expression triggers prosurvival signaling and contributes to cell survival, invasive motility, and chemoresistance in many kinds of cancers. In addition, recent reports suggested that MerTK could be a primary target for abnormal platelet aggregation. Consequently, MerTK inhibitors may promote cancer cell death, sensitize cells to chemotherapy, and act as new antiplatelet agents. We screened an inhouse chemical library to discover novel small-molecule MerTK inhibitors, and identified AZD7762, which is known as a checkpoint-kinase (Chk) inhibitor. The inhibition of MerTK by AZD7762 was validated using an in vitro homogeneous time-resolved fluorescence (HTRF) assay and through monitoring the decrease in phosphorylated MerTK in two lung cancer cell lines. We also determined the crystal structure of the MerTK:AZD7762 complex and revealed the binding mode of AZD7762 to MerTK. Structural information from the MerTK:AZD7762 complex and its comparison with other MerTK:inhibitor structures gave us new insights for optimizing the development of inhibitors targeting MerTK.Keywords
Funding Information
- National Cancer Center (1910031)
- National Research Foundation of Korea (NRF-2018R1A5A2023127, NRF-2019R1A2C1002545)
This publication has 51 references indexed in Scilit:
- Towards automated crystallographic structure refinement with phenix.refineActa Crystallographica Section D Structural Biology, 2012
- Galectin‐3 is a new MerTK‐specific eat‐me signalJournal of Cellular Physiology, 2011
- Features and development of CootActa Crystallographica Section D Structural Biology, 2010
- PHENIX: a comprehensive Python-based system for macromolecular structure solutionActa Crystallographica Section D Structural Biology, 2010
- electronic Ligand Builder and Optimization Workbench(eLBOW): a tool for ligand coordinate and restraint generationActa Crystallographica Section D Structural Biology, 2009
- Structural insights into the inhibited states of the Mer receptor tyrosine kinaseJournal of Structural Biology, 2009
- TAM Receptor Tyrosine Kinases: Biologic Functions, Signaling, and Potential Therapeutic Targeting in Human Cancer2008
- Phasercrystallographic softwareJournal of Applied Crystallography, 2007
- A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregationBlood, 2006
- [20] Processing of X-ray diffraction data collected in oscillation mode1997